Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
CRANFORD, N.J., Oct. 15, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ:CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the MicroCap Rodeo on Oct 16 th at 9:45-10:15 AM in room 416B. The conference is being held at the Hilton Austin in Austin, Texas on October 15-16, 2019.
Mr. Leonard Mazur, Chairman, of Citius Pharmaceuticals will be delivering a presentation, as well as answering questions from investors. Earlier in the month, Citius Pharmaceuticals, reached the interim analysis milestone for Mino-Lok® Phase III pivotal trial. To access Citius Pharmaceuticals live webcast please use the following link: https://www.webcaster4.com/Webcast/Page/2134/31874
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Citius Pharmaceuticals, Inc. will also be available for one-on-one meetings. To arrange a meeting with the Company, please contact Mr. Andrew Scott: ascott@citiuspharma.com.
About MicroCap Rodeo
Bucking the trend of microcap conferences is the first-annual MicroCap Rodeo in Austin, Texas. This year's theme: Lassoing the "Best Ideas."
Over two days in October, investors can harness top stocks for their portfolios. They'll meet with executive management teams from approximately 50-plus microcap companies across a wide variety of industries and gain an understanding into the key value drivers and potential trends for 2020. Complementing the interactive, in-depth 30-minute one-on-one meeting format will be four tracks of company presentations.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
When they're not wrangling great ideas, investors can dig into delicious Texas food, entertainment and surprise guests.
About Citius Pharmaceuticals, Inc.
Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously-approved active pharmaceutical ingredients. We seek to achieve leading market positions by providing therapeutic products that address unmet medical needs; by using previously approved drugs with substantial safety and efficacy data, we seek to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, please visit www.citiuspharma.com.
Contact:
Andrew Scott
Vice President, Corporate Development
(O) 908-967-6677 x105
ascott@citiuspharma.com
SOURCE Citius Pharmaceuticals, Inc.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.